Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Surg Endosc ; 26(10): 2961-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22580874

ABSTRACT

BACKGROUND: Within the next few years, the medical industry will launch increasingly affordable three-dimensional (3D) vision systems for the operating room (OR). This study aimed to evaluate the effect of two-dimensional (2D) and 3D visualization on surgical skills and task performance. METHODS: In this study, 34 individuals with varying laparoscopic experience (18 inexperienced individuals) performed three tasks to test spatial relationships, grasping and positioning, dexterity, precision, and hand-eye and hand-hand coordination. Each task was performed in 3D using binocular vision for open performance, the Viking 3Di Vision System for laparoscopic performance, and the DaVinci robotic system. The same tasks were repeated in 2D using an eye patch for monocular vision, conventional laparoscopy, and the DaVinci robotic system. RESULTS: Loss of 3D vision significantly increased the perceived difficulty of a task and the time required to perform it, independently of the approach (P < 0.0001-0.02). Simple tasks took 25 % to 30 % longer to complete and more complex tasks took 75 % longer with 2D than with 3D vision. Only the difficult task was performed faster with the robot than with laparoscopy (P = 0.005). In every case, 3D robotic performance was superior to conventional laparoscopy (2D) (P < 0.001-0.015). CONCLUSIONS: The more complex the task, the more 3D vision accelerates task completion compared with 2D vision. The gain in task performance is independent of the surgical method.


Subject(s)
Imaging, Three-Dimensional/instrumentation , Laparoscopy/instrumentation , Robotics/instrumentation , Surgery, Computer-Assisted/instrumentation , Task Performance and Analysis , Adult , Aminophylline , Analysis of Variance , Depth Perception , Female , Humans , Imaging, Three-Dimensional/methods , Male , Middle Aged , Operative Time , Robotics/methods , Time and Motion Studies , Young Adult
2.
Cancer Gene Ther ; 15(10): 636-44, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18535617

ABSTRACT

Overexpression of the transcription factor E2F-1 induces apoptosis in tumor cells. This apoptotic effect is partly mediated through the induction of the double-stranded RNA-activated protein kinase (PKR). Here, we investigate if agents that upregulate PKR could enhance the apoptotic effect of E2F-1 overexpression in liver tumors. In human hepatocellular carcinoma (HCC) cells (Hep3B, HepG2, Huh7), adenovirus-mediated overexpression of E2F-1 (AdCMV-E2F) transcriptionally increased PKR mRNA. The subsequent increase of total and phosphorylated PKR protein was followed by induction of apoptosis. When AdCMV-E2F was combined with the PKR modifier interferon alpha (IFNalpha), PKR was additionally upregulated and both PKR activation and apoptosis were increased. Subcutaneous xenograft tumors were selectively targeted using an adenoviral vector expressing E2F-1 under the control of the human telomerase reverse transcriptase (hTERT) promoter (AdhTERT-E2F). Weekly systemic administration of AdhTERT-E2F inhibited tumor growth. The tumor suppressive effect of AdhTERT-E2F therapy was further enhanced in combination with IFNalpha.Our results demonstrate that PKR activating agents enhance the anti-tumor effect of E2F-1 overexpression in HCC in-vitro and in-vivo. Hence, modulation of PKR is a potential strategy to increase the efficacy of PKR-dependent anti-tumor therapies.


Subject(s)
Carcinoma, Hepatocellular/therapy , E2F1 Transcription Factor/physiology , Genetic Therapy/methods , Interferon-alpha/physiology , Liver Neoplasms/therapy , eIF-2 Kinase/metabolism , Adenoviridae/genetics , Animals , Apoptosis/genetics , Apoptosis/physiology , Blotting, Western , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Cell Survival/genetics , Cell Survival/physiology , E2F1 Transcription Factor/genetics , Genetic Vectors/genetics , Humans , Interferon-alpha/genetics , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Male , Mice , Mice, Nude , Polymerase Chain Reaction , Xenograft Model Antitumor Assays , eIF-2 Kinase/genetics
3.
Br J Surg ; 93(11): 1390-3, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16862615

ABSTRACT

BACKGROUND: The effectiveness of various appendiceal stump closure methods has not been evaluated systematically. The aim of this study was to compare the morbidity of stump closure by stapling or use of endoloops. METHODS: A non-concurrent cohort study of prospectively acquired data was performed. The primary outcome variable was the rate of intra-abdominal surgical-site infection. Secondary outcome measures were complications, duration of intervention, hospital stay, rate of readmission to hospital and the difference in direct costs of the operation. RESULTS: Staples were used in 60.5 per cent and endoloops in 39.5 per cent of 6486 patients operated on for suspected appendicitis between January 1995 and December 2003. Among 4489 patients with acute appendicitis the rate of intra-abdominal surgical-site infection was 0.7 per cent in the stapler group and 1.7 per cent in the endoloop group (P = 0.004). The rate of readmission to hospital was 0.9 and 2.1 per cent respectively (P = 0.001). CONCLUSION: Application of a stapler for transection and closure of the appendiceal stump in patients with acute appendicitis lowered the risk of postoperative intra-abdominal surgical-site infection and the need for readmission to hospital.


Subject(s)
Appendectomy/methods , Appendicitis/surgery , Postoperative Complications/etiology , Suture Techniques , Adult , Appendectomy/economics , Cohort Studies , Costs and Cost Analysis , Humans , Length of Stay , Postoperative Complications/economics , Prospective Studies , Surgical Stapling/economics , Surgical Wound Infection/economics , Surgical Wound Infection/etiology , Suture Techniques/economics , Treatment Outcome
4.
Ther Umsch ; 63(5): 301-9, 2006 May.
Article in German | MEDLINE | ID: mdl-16739888

ABSTRACT

Novel means to locate and treat lower gastrointestinal bleeding (lGB) allow to reduce the rate of required surgical interventions and help to limit the extend of resection. The risk stratification of patients with lGB is the primary step of our recommended treatment algorithm. Accordingly, risk stratifying instruments, which are only partly validated up to now, are gaining significance in lGB. Whereas, gastro-duodenoscopy and colonoscopy prior to angiography or scintigraphy are established diagnostic tools, capsule enteroscopy offers a novel approach to hemodynamic stable patients with lGB that are difficult to localize. With its every increasing sensitivity, Angio-Computer Tomography is likely to replace scintigraphy and diagnostic angiography in the very near future. In addition, recent advances in superselective microembolisation have been shown to have the potential rendering surgical interventions in a majority of patients with acute lGB unnecessary. The extend of required surgical resection is largely dependent on the success to localize the bleeding source of prior diagnostics. Only if the source is identified, a limited segmental resection should be performed. Should surgery be required, we suggest to maintain the effort to localize the bleeding, either by prior laparoscopy and/or by intraoperative entero-colonoscopy. Eventually, if the source of bleeding remains unclear total colectomy with ileorectal anastomosis represents the procedure of choice in patients with acute lGB.


Subject(s)
Algorithms , Decision Support Systems, Clinical , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/therapy , Intestinal Diseases/diagnosis , Intestinal Diseases/therapy , Practice Guidelines as Topic , Acute Disease , Critical Care/methods , Evidence-Based Medicine/methods , Germany , Humans , Practice Patterns, Physicians'
5.
Cancer Gene Ther ; 13(5): 490-502, 2006 May.
Article in English | MEDLINE | ID: mdl-16282987

ABSTRACT

Current therapies used in the treatment of breast cancer are limited by systemic toxicity, rapid drug metabolism and intrinsic and acquired drug resistance. We have previously shown that adenoviral-mediated transfer of the melanoma differentiation-associated gene-7 (mda-7) elicits growth inhibition and apoptosis in various tumor types. Here, we evaluate the effects of Ad-mda7, alone and in combination with other therapies, against a panel of nine breast tumor cell lines and their normal counterparts; we report selective Ad-mda7-mediated p53-independent growth inhibition, G2/M cell cycle arrest, and apoptosis. In vivo, Ad-mda7 induced p53-independent tumor growth inhibition (P<0.004) in multiple xenograft models. We then evaluated the combination of Ad-mda7 with agents commonly used to treat breast cancer: radiotherapy (XRT), Tamoxifen, Taxotere, Adriamycin, and Herceptin. These agents exhibit diverse modes of action, including formation of bulky adducts, inhibition of DNA replication (Adriamycin, XRT), damage to microtubules (Taxotere), nonsteroidal estrogen antagonists (Tamoxifen), or Her2/neu receptor blockade (Herceptin). Treated with conventional anticancer drugs or radiation, MDA-7-expressing cells display additive or synergistic cytotoxicity and apoptosis that correlates with decreased BCL-2 expression and BAX upregulation. In vivo, animals that received Ad-mda7 and XRT underwent significant reduction of tumor growth (P<0.002). This is the first report of the synergistic effects of Ad-mda7 combined with chemotherapy or radiotherapy on human breast carcinoma cells.


Subject(s)
Breast Neoplasms/therapy , Carcinoma/therapy , Genetic Therapy , Interleukins/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Adenoviridae/genetics , Animals , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Apoptosis , Biological Therapy , Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Carcinoma/drug therapy , Carcinoma/radiotherapy , Combined Modality Therapy , Female , Gene Transfer Techniques , Humans , Mice , Mice, Inbred BALB C , Proto-Oncogene Proteins c-bcl-2/analysis
6.
Dis Colon Rectum ; 41(3): 389-90, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9514438

ABSTRACT

The York-Mason approach to the rectum with resection of the coccyx provides an excellent exposure for the treatment of large villous adenomas and low-risk rectal cancers. Morbidity related to this operation primarily arises as local infection (septic pelvis, fistulation), chronic coccygeal pain, and fecal incontinence. This is the first report to describe a pelvic floor herniation two years after a York-Mason approach to the rectum.


Subject(s)
Pelvic Floor , Postoperative Complications , Rectum/surgery , Aged , Digestive System Surgical Procedures/adverse effects , Digestive System Surgical Procedures/methods , Female , Hernia/etiology , Humans , Rectal Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...